PHARVARIS N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.46 USD | +4.33% |
|
-5.04% | -23.49% |
| May. 09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
| May. 08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARVARIS N.V. | Other Biotechnology & Medical Research | +4.33% | -5.04% | -23.49% | +161.39% | - | 1.15B |  | |  |
- Stock Market
- Equities
- PHVS Stock
- Charts Pharvaris N.V.
- Relative Strength Chart
